483 Hisun Pharmaceutical Hangzhou Mar 2018

483 Hisun Pharmaceutical Hangzhou Mar 2018

Peter Baker FDA, Christopher Middendorf FDA$119.00 - Available Now

FDA investigators audited the Hisun Pharmaceutical Hangzhou - Hangzhou, China facility and issued inspectional observations (via FDA 483) on 06 Mar 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 06 Mar 2018
  • Location: Hangzhou, China
  • FEI: 3008481334
Add To Cart